These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 313275)
1. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP. Leclerc C; Juy D; Bourgeois E; Chedid L Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275 [No Abstract] [Full Text] [Related]
2. Enhancement by muramyl dipeptide of in vitro nude mice responses to a T-dependent antigen. Leclerc C; Bourgeois E; Chedid L Immunol Commun; 1979; 8(1):55-64. PubMed ID: 311334 [TBL] [Abstract][Full Text] [Related]
3. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity. Leclerc C; Bourgeois E; Chedid L Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118 [TBL] [Abstract][Full Text] [Related]
4. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions. Souvannavong V; Adam A Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response. Lowy I; Theze J; Chedid L J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289 [TBL] [Abstract][Full Text] [Related]
6. The macrophage, target cell of the synthetic adjuvant muramyl dipeptide. Fevrier M; Birrien JL; Leclerc C; Chedid L; Liacopoulos P Eur J Immunol; 1978 Aug; 8(8):558-62. PubMed ID: 359336 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs. Saiki I; Tanio Y; Yamawaki M; Uemiya M; Kobayashi S; Fukuda T; Yukimasa H; Yamamura Y; Azuma I Infect Immun; 1981 Jan; 31(1):114-21. PubMed ID: 6971259 [TBL] [Abstract][Full Text] [Related]
8. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine. Heymer B; Finger H; Wirsing CH Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536 [TBL] [Abstract][Full Text] [Related]
9. Restoration and stimulation of the in vitro immune response of B cells to sheep erythrocytes by interleukins and muramyl dipeptide (MDP). Souvannavong V; Adam A Biochem Biophys Res Commun; 1984 Nov; 125(1):431-9. PubMed ID: 6334520 [TBL] [Abstract][Full Text] [Related]
10. Lack of immunostimulatory effect of N-acetyl muramyl-L-alanyl-D-isoglutamine on selected chicken immune functions. Neumann U; Wischner H; Siegmann O Comp Immunol Microbiol Infect Dis; 1982; 5(4):413-21. PubMed ID: 7172620 [TBL] [Abstract][Full Text] [Related]
11. In vitro immune response to sheep erythrocytes in macrophage depleted cultures. Restoration with interleukine 1 or a monokine from resident macrophages and stimulation by N-acetyl-muramyl-L-alanyl-D-isoglutamine (MDP). Souvannavong V; Rimsky L; Adam A Biochem Biophys Res Commun; 1983 Jul; 114(2):721-8. PubMed ID: 6603843 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of in vitro immune responses of murine Peyer's patch cultures by concanavalin A, muramyl dipeptide and lipopolysaccharide. Kiyono H; McGhee JR; Kearney JF; Michalek SM Scand J Immunol; 1982 Apr; 15(4):329-39. PubMed ID: 7048508 [No Abstract] [Full Text] [Related]
13. Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice. Phillips NC; Chedid L Infect Immun; 1987 Jun; 55(6):1426-30. PubMed ID: 3553001 [TBL] [Abstract][Full Text] [Related]
14. N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture. Dewhirst FE Infect Immun; 1982 Jan; 35(1):133-7. PubMed ID: 7054120 [TBL] [Abstract][Full Text] [Related]
15. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process. Fidler IJ J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201 [No Abstract] [Full Text] [Related]
16. Study of immunomodulatory properties of N-acetylmuramyl-L-alanyl-D-isoglutamine and N-acetylglucosaminyl-(beta 1----4)-N-acetylmuramyl-L-alanyl-D-isoglutamine. Dozmorov IM; Kuzin II; Lutsan NI; Lutsenko GV; Prokhorova AL; Sapozhnikov AM; Andronova TM; Ivanov VT Biomed Sci; 1991; 2(6):651-8. PubMed ID: 1841635 [TBL] [Abstract][Full Text] [Related]
17. Specific impaired alloreactivity of mice immunized with syngeneic MLCT-lymphoblasts using muramylpeptides as adjuvant. Binz H; Tarcsay L; Wigzell H; Dukor P Transplant Proc; 1981 Mar; 13(1 Pt 1):566-73. PubMed ID: 6455801 [No Abstract] [Full Text] [Related]
18. Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice. Fraser-Smith EB; Waters RV; Matthews TR Infect Immun; 1982 Jan; 35(1):105-10. PubMed ID: 7054119 [TBL] [Abstract][Full Text] [Related]
19. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18). Akasaki M; Takashi T; Kita Y; Tsukada W Agents Actions; 1987 Oct; 22(1-2):144-50. PubMed ID: 3318323 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of mitogen-induced polyclonal activation by by a synthetic adjuvant, muramyl dipeptide (MDP). Löwy I; Leclerc C; Bourgeois E; Chedid L J Immunol; 1980 Jan; 124(1):320-5. PubMed ID: 6985643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]